Graig Suvannavejh

Stock Analyst at Mizuho

(0.8)
# 2331
Out of 5,370 analysts
179
Total ratings
40.00%
Success rate
-7.30%
Average return
45 Stocks
Name Action PT Current % Upside Ratings Updated
INSM Insmed
Maintains: Outperform
96 110
101.26 8.63% 7 Jun 11, 2025
CRVS Corvus Pharma
Maintains: Outperform
12 11
4.23 160.05% 2 May 20, 2025
EYPT EyePoint Pharmaceuti...
Maintains: Outperform
30 26
8.88 192.79% 5 May 16, 2025
HRMY Harmony Biosciences ...
Maintains: Outperform
44 48
32.94 45.72% 18 May 15, 2025
APLS Apellis Pharmaceutic...
Maintains: Neutral
30 20
18.32 9.17% 7 May 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
7 8
5.43 47.33% 7 May 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
38 33
32.63 1.13% 8 Apr 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
212 216
101.88 112.01% 21 Mar 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
140 132
n/a n/a 11 Feb 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
3 2
n/a n/a 2 Nov 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
7 8
2.04 272.55% 1 Nov 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
74 74
8.68 752.53% 1 Sep 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
5 1
n/a n/a 3 Sep 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
44 49
53.85 -9.01% 6 Jul 22, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
50
22.4 123.21% 1 Jul 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
20
0.87 2198.85% 1 Jul 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
14 16
6.1 162.3% 3 May 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
40 22
2.46 794.31% 4 Apr 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
20 8
2.36 238.98% 1 Apr 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
25 45
n/a n/a 9 Feb 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
17 10
4.01 149.38% 5 Nov 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
10 9
1.5 500% 4 Nov 17, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
64
1.7 3664.71% 8 Aug 23, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
274 258
n/a n/a 3 Aug 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
17 1
3.27 -69.42% 5 Jun 5, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
15
7.87 90.6% 1 Mar 31, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
31 35
62.34 -43.86% 5 Nov 10, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
9 8
3.77 112.2% 6 Nov 10, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
71 57
33.75 68.89% 2 May 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sell
8 5
35.61 -85.96% 4 Apr 19, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
20 18
n/a n/a 2 Oct 6, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
8 6
n/a n/a 2 Aug 6, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
53
n/a n/a 1 Jul 13, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
34
5.98 468.56% 1 Jun 1, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
28
3.85 627.27% 1 Apr 20, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
31
14.66 111.46% 1 Apr 19, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Sell
19
n/a n/a 1 Mar 2, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
5
1.85 156.76% 1 Nov 24, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
36
13.38 169.06% 2 Nov 9, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Sell
n/a
n/a n/a 1 Oct 21, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
37
0.97 3714.43% 1 Oct 20, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Sell
128
109.64 16.75% 1 Sep 14, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
25 10
n/a n/a 1 Aug 25, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
29
n/a n/a 1 Mar 12, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
35
n/a n/a 1 Jan 8, 2020